Zhicheng Yao

1.9k total citations
63 papers, 1.2k citations indexed

About

Zhicheng Yao is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Zhicheng Yao has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 21 papers in Cancer Research and 13 papers in Epidemiology. Recurrent topics in Zhicheng Yao's work include Circular RNAs in diseases (14 papers), RNA modifications and cancer (13 papers) and MicroRNA in disease regulation (12 papers). Zhicheng Yao is often cited by papers focused on Circular RNAs in diseases (14 papers), RNA modifications and cancer (13 papers) and MicroRNA in disease regulation (12 papers). Zhicheng Yao collaborates with scholars based in China, United States and Hong Kong. Zhicheng Yao's co-authors include Kunpeng Hu, Zhiyong Xiong, Meihai Deng, Bo Liu, He Huang, Jizong Lin, Nan Lin, Mingxing Xu, Jingyan Luo and Zejian Huang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Zhicheng Yao

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhicheng Yao China 19 798 625 159 154 139 63 1.2k
Mian He China 18 1.1k 1.4× 811 1.3× 104 0.7× 200 1.3× 165 1.2× 41 1.7k
Tianyi Gao China 20 777 1.0× 598 1.0× 111 0.7× 153 1.0× 51 0.4× 47 1.3k
Yajin Chen China 15 550 0.7× 340 0.5× 127 0.8× 99 0.6× 195 1.4× 43 959
Kunlin Xie China 19 827 1.0× 635 1.0× 196 1.2× 115 0.7× 152 1.1× 46 1.3k
Pedram Kharaziha Sweden 14 795 1.0× 427 0.7× 240 1.5× 189 1.2× 175 1.3× 25 1.4k
Jiaming Lai China 17 484 0.6× 259 0.4× 286 1.8× 155 1.0× 249 1.8× 57 1.1k
Xiaodan Huang China 18 666 0.8× 557 0.9× 187 1.2× 133 0.9× 34 0.2× 50 1.3k
Liming Chen China 16 494 0.6× 230 0.4× 348 2.2× 208 1.4× 351 2.5× 54 1.3k
Daniel Lin United States 16 327 0.4× 290 0.5× 261 1.6× 87 0.6× 36 0.3× 50 1.0k
Verena Köberle Germany 15 546 0.7× 443 0.7× 64 0.4× 194 1.3× 163 1.2× 19 898

Countries citing papers authored by Zhicheng Yao

Since Specialization
Citations

This map shows the geographic impact of Zhicheng Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhicheng Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhicheng Yao more than expected).

Fields of papers citing papers by Zhicheng Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhicheng Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhicheng Yao. The network helps show where Zhicheng Yao may publish in the future.

Co-authorship network of co-authors of Zhicheng Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhicheng Yao. A scholar is included among the top collaborators of Zhicheng Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhicheng Yao. Zhicheng Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Yupeng, Yuxuan Li, Zhiyong Xiong, et al.. (2025). CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt/β-catenin pathway via the miR-452-5p/SOX15 axis. Genomics. 117(2). 110999–110999. 4 indexed citations
2.
Yao, Zhicheng, Yupeng Ren, Yuxuan Li, et al.. (2025). Comparative analysis of hepatectomy for HCC with PVTT: Insights from a 30-year single-center experience. Surgical Oncology. 60. 102211–102211.
3.
Ren, Yupeng, Yuxuan Li, Hao Liang, et al.. (2025). CircRNA‐mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c‐Myc Axis. Advanced Science. 12(20). e2410591–e2410591. 4 indexed citations
4.
Li, Ling, Zhicheng Yao, Kevan J. Salimian, et al.. (2024). Extracellular Vesicles Delivered by a Nanofiber‐Hydrogel Composite Enhance Healing In Vivo in a Model of Crohn's Disease Perianal Fistula. Advanced Healthcare Materials. 14(7). e2402292–e2402292. 7 indexed citations
5.
Guo, Rui, Bowen Zheng, Tao Wu, et al.. (2024). Two-year prognosis of multinodular goiter following radiofrequency ablation based on all nodule burdens. European Thyroid Journal. 13(1).
7.
Ouyang, Juan, Lihe Sun, Rong Li, et al.. (2024). Microneedle System with Biomarker-Activatable Chromophore as Both Optical Imaging Probe and Anti-bacterial Agent for Combination Therapy of Bacterial-Infected Wounds and Outcome Monitoring. ACS Applied Materials & Interfaces. 16(16). 20315–20328. 8 indexed citations
8.
Liu, Chunhong, Xinzhi Li, Zhicheng Yao, Xueying Li, & Zheng Chen. (2023). Hepatocyte-specific deletion of Mettl3 promotes hepatocellular carcinoma in mice. Genes & Diseases. 11(1). 57–59. 3 indexed citations
9.
Ren, Yupeng, Yuxuan Li, Junfeng Deng, et al.. (2023). Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis. International Journal of Biological Sciences. 19(12). 3678–3693. 12 indexed citations
11.
Chen, Long, Zhicheng Yao, Siqin Zhang, et al.. (2022). Biomaterial-induced macrophage polarization for bone regeneration. Chinese Chemical Letters. 34(6). 107925–107925. 30 indexed citations
12.
Ren, Yupeng, Yuxuan Li, Francisco Tustumi, et al.. (2022). Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis. Annals of Translational Medicine. 10(14). 769–769. 9 indexed citations
14.
Wu, Yun, Xinyu Yang, Zhicheng Yao, et al.. (2020). C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3. PLoS neglected tropical diseases. 14(3). e0008083–e0008083. 33 indexed citations
15.
Yao, Zhicheng, et al.. (2020). A Novel Strategy for Single-Session Ultrasound-Guided Radiofrequency Ablation of Large Benign Thyroid Nodules: A Pilot Cohort Study. Frontiers in Endocrinology. 11. 560508–560508. 7 indexed citations
16.
Liang, Hao, Zhiyong Xiong, Ruixi Li, et al.. (2019). BDH2 is downregulated in hepatocellular carcinoma and acts as a tumor suppressor regulating cell apoptosis and autophagy. Journal of Cancer. 10(16). 3735–3745. 21 indexed citations
17.
Zhu, Ting, Shu An, Junhao Zhou, et al.. (2018). LncRNA DUXAP9‐206 directly binds with Cbl‐b to augment EGFR signaling and promotes non‐small cell lung cancer progression. Journal of Cellular and Molecular Medicine. 23(3). 1852–1864. 14 indexed citations
18.
Liang, Hao, Zhiyong Xiong, Zhicheng Yao, et al.. (2018). Inhibiting effect and its mechanism of BDH2 gene on the proliferation of liver cancer cells. 7(4). 327–331. 1 indexed citations
19.
Yao, Zhicheng, Jingyan Luo, Kunpeng Hu, et al.. (2017). ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways. Molecular Oncology. 11(4). 422–437. 256 indexed citations
20.
Liu, Bo, Zhicheng Yao, Kunpeng Hu, et al.. (2015). ShRNA-mediated silencing of the Ndc80 gene suppress cell proliferation and affected hepatitis B virus-related hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 40(3). 297–303. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026